High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer

BACKGROUND: We previously showed that α3β1 integrin is a novel cancer biomarker and drug target in non-small cell lung cancer (NSCLC). This study characterized the integrin α3 (ITGA3) expression on patient specimens. METHODS: Tissue microarrays (TMAs) were prepared from archival tissue blocks contai...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transl Lung Cancer Res
Main Authors: Li, Qianping, Ma, Weijie, Chen, Shuai, Tian, Eddie C., Wei, Sixi, Fan, Reggie R., Wang, Tao, Zhou, Chihong, Li, Tianhong
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7481578/
https://ncbi.nlm.nih.gov/pubmed/32953510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-19-633
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki